The global Precision Cancer Diagnostic Solutions market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Precision Cancer Diagnostic Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Diagnostic Solutions.

Report Scope

The Precision Cancer Diagnostic Solutions market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Precision Cancer Diagnostic Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Precision Cancer Diagnostic Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Precision Cancer Diagnostic Solutions Market Report

Report Metric	Details
Report Name	Precision Cancer Diagnostic Solutions Market
CAGR	5%
Segment by Type	Hardware Software and Services
Segment by Application	Hospital & Diagnostic Centers Laboratories & Research Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Philips Healthcare, Thermo Fisher Scientific, Abbott Laboratories, BD, Siemens Healthineers, PHC Holdings, Agilent, Sakura Finetek, Epredia, bioMeriux, MDx Health, DiaSorin
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Cancer Diagnostic Solutions companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Precision Cancer Diagnostic Solutions Market report?

Ans: The main players in the Precision Cancer Diagnostic Solutions Market are Philips Healthcare, Thermo Fisher Scientific, Abbott Laboratories, BD, Siemens Healthineers, PHC Holdings, Agilent, Sakura Finetek, Epredia, bioMeriux, MDx Health, DiaSorin

What are the Application segmentation covered in the Precision Cancer Diagnostic Solutions Market report?

Ans: The Applications covered in the Precision Cancer Diagnostic Solutions Market report are Hospital & Diagnostic Centers, Laboratories & Research Institutes

What are the Type segmentation covered in the Precision Cancer Diagnostic Solutions Market report?

Ans: The Types covered in the Precision Cancer Diagnostic Solutions Market report are Hardware, Software and Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Precision Cancer Diagnostic Solutions Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Hardware

1.2.3 Software and Services

1.3 Market by Application

1.3.1 Global Precision Cancer Diagnostic Solutions Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital & Diagnostic Centers

1.3.3 Laboratories & Research Institutes

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Precision Cancer Diagnostic Solutions Market Perspective (2019-2030)

2.2 Precision Cancer Diagnostic Solutions Growth Trends by Region

2.2.1 Global Precision Cancer Diagnostic Solutions Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Precision Cancer Diagnostic Solutions Historic Market Size by Region (2019-2024)

2.2.3 Precision Cancer Diagnostic Solutions Forecasted Market Size by Region (2025-2030)

2.3 Precision Cancer Diagnostic Solutions Market Dynamics

2.3.1 Precision Cancer Diagnostic Solutions Industry Trends

2.3.2 Precision Cancer Diagnostic Solutions Market Drivers

2.3.3 Precision Cancer Diagnostic Solutions Market Challenges

2.3.4 Precision Cancer Diagnostic Solutions Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Precision Cancer Diagnostic Solutions Players by Revenue

3.1.1 Global Top Precision Cancer Diagnostic Solutions Players by Revenue (2019-2024)

3.1.2 Global Precision Cancer Diagnostic Solutions Revenue Market Share by Players (2019-2024)

3.2 Global Precision Cancer Diagnostic Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Precision Cancer Diagnostic Solutions Revenue

3.4 Global Precision Cancer Diagnostic Solutions Market Concentration Ratio

3.4.1 Global Precision Cancer Diagnostic Solutions Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Diagnostic Solutions Revenue in 2023

3.5 Precision Cancer Diagnostic Solutions Key Players Head office and Area Served

3.6 Key Players Precision Cancer Diagnostic Solutions Product Solution and Service

3.7 Date of Enter into Precision Cancer Diagnostic Solutions Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Precision Cancer Diagnostic Solutions Breakdown Data by Type

4.1 Global Precision Cancer Diagnostic Solutions Historic Market Size by Type (2019-2024)

4.2 Global Precision Cancer Diagnostic Solutions Forecasted Market Size by Type (2025-2030)

5 Precision Cancer Diagnostic Solutions Breakdown Data by Application

5.1 Global Precision Cancer Diagnostic Solutions Historic Market Size by Application (2019-2024)

5.2 Global Precision Cancer Diagnostic Solutions Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Precision Cancer Diagnostic Solutions Market Size (2019-2030)

6.2 North America Precision Cancer Diagnostic Solutions Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Precision Cancer Diagnostic Solutions Market Size by Country (2019-2024)

6.4 North America Precision Cancer Diagnostic Solutions Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Precision Cancer Diagnostic Solutions Market Size (2019-2030)

7.2 Europe Precision Cancer Diagnostic Solutions Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Precision Cancer Diagnostic Solutions Market Size by Country (2019-2024)

7.4 Europe Precision Cancer Diagnostic Solutions Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Precision Cancer Diagnostic Solutions Market Size (2019-2030)

8.2 Asia-Pacific Precision Cancer Diagnostic Solutions Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Precision Cancer Diagnostic Solutions Market Size by Region (2019-2024)

8.4 Asia-Pacific Precision Cancer Diagnostic Solutions Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Precision Cancer Diagnostic Solutions Market Size (2019-2030)

9.2 Latin America Precision Cancer Diagnostic Solutions Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Precision Cancer Diagnostic Solutions Market Size by Country (2019-2024)

9.4 Latin America Precision Cancer Diagnostic Solutions Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Precision Cancer Diagnostic Solutions Market Size (2019-2030)

10.2 Middle East & Africa Precision Cancer Diagnostic Solutions Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Precision Cancer Diagnostic Solutions Market Size by Country (2019-2024)

10.4 Middle East & Africa Precision Cancer Diagnostic Solutions Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Philips Healthcare

11.1.1 Philips Healthcare Company Detail

11.1.2 Philips Healthcare Business Overview

11.1.3 Philips Healthcare Precision Cancer Diagnostic Solutions Introduction

11.1.4 Philips Healthcare Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024)

11.1.5 Philips Healthcare Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Detail

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Precision Cancer Diagnostic Solutions Introduction

11.2.4 Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 Abbott Laboratories

11.3.1 Abbott Laboratories Company Detail

11.3.2 Abbott Laboratories Business Overview

11.3.3 Abbott Laboratories Precision Cancer Diagnostic Solutions Introduction

11.3.4 Abbott Laboratories Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024)

11.3.5 Abbott Laboratories Recent Development

11.4 BD

11.4.1 BD Company Detail

11.4.2 BD Business Overview

11.4.3 BD Precision Cancer Diagnostic Solutions Introduction

11.4.4 BD Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024)

11.4.5 BD Recent Development

11.5 Siemens Healthineers

11.5.1 Siemens Healthineers Company Detail

11.5.2 Siemens Healthineers Business Overview

11.5.3 Siemens Healthineers Precision Cancer Diagnostic Solutions Introduction

11.5.4 Siemens Healthineers Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024)

11.5.5 Siemens Healthineers Recent Development

11.6 PHC Holdings

11.6.1 PHC Holdings Company Detail

11.6.2 PHC Holdings Business Overview

11.6.3 PHC Holdings Precision Cancer Diagnostic Solutions Introduction

11.6.4 PHC Holdings Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024)

11.6.5 PHC Holdings Recent Development

11.7 Agilent

11.7.1 Agilent Company Detail

11.7.2 Agilent Business Overview

11.7.3 Agilent Precision Cancer Diagnostic Solutions Introduction

11.7.4 Agilent Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024)

11.7.5 Agilent Recent Development

11.8 Sakura Finetek

11.8.1 Sakura Finetek Company Detail

11.8.2 Sakura Finetek Business Overview

11.8.3 Sakura Finetek Precision Cancer Diagnostic Solutions Introduction

11.8.4 Sakura Finetek Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024)

11.8.5 Sakura Finetek Recent Development

11.9 Epredia

11.9.1 Epredia Company Detail

11.9.2 Epredia Business Overview

11.9.3 Epredia Precision Cancer Diagnostic Solutions Introduction

11.9.4 Epredia Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024)

11.9.5 Epredia Recent Development

11.10 bioMeriux

11.10.1 bioMeriux Company Detail

11.10.2 bioMeriux Business Overview

11.10.3 bioMeriux Precision Cancer Diagnostic Solutions Introduction

11.10.4 bioMeriux Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024)

11.10.5 bioMeriux Recent Development

11.11 MDx Health

11.11.1 MDx Health Company Detail

11.11.2 MDx Health Business Overview

11.11.3 MDx Health Precision Cancer Diagnostic Solutions Introduction

11.11.4 MDx Health Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024)

11.11.5 MDx Health Recent Development

11.12 DiaSorin

11.12.1 DiaSorin Company Detail

11.12.2 DiaSorin Business Overview

11.12.3 DiaSorin Precision Cancer Diagnostic Solutions Introduction

11.12.4 DiaSorin Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024)

11.12.5 DiaSorin Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Philips Healthcare

Thermo Fisher Scientific

List of Tables

Table 1. Global Precision Cancer Diagnostic Solutions Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Hardware

Table 3. Key Players of Software and Services

Table 4. Global Precision Cancer Diagnostic Solutions Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Precision Cancer Diagnostic Solutions Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Precision Cancer Diagnostic Solutions Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Precision Cancer Diagnostic Solutions Market Share by Region (2019-2024)

Table 8. Global Precision Cancer Diagnostic Solutions Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Precision Cancer Diagnostic Solutions Market Share by Region (2025-2030)

Table 10. Precision Cancer Diagnostic Solutions Market Trends

Table 11. Precision Cancer Diagnostic Solutions Market Drivers

Table 12. Precision Cancer Diagnostic Solutions Market Challenges

Table 13. Precision Cancer Diagnostic Solutions Market Restraints

Table 14. Global Precision Cancer Diagnostic Solutions Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Precision Cancer Diagnostic Solutions Market Share by Players (2019-2024)

Table 16. Global Top Precision Cancer Diagnostic Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Solutions as of 2023)

Table 17. Ranking of Global Top Precision Cancer Diagnostic Solutions Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Precision Cancer Diagnostic Solutions Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Precision Cancer Diagnostic Solutions Product Solution and Service

Table 21. Date of Enter into Precision Cancer Diagnostic Solutions Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Precision Cancer Diagnostic Solutions Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Precision Cancer Diagnostic Solutions Revenue Market Share by Type (2019-2024)

Table 25. Global Precision Cancer Diagnostic Solutions Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Precision Cancer Diagnostic Solutions Revenue Market Share by Type (2025-2030)

Table 27. Global Precision Cancer Diagnostic Solutions Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Precision Cancer Diagnostic Solutions Revenue Market Share by Application (2019-2024)

Table 29. Global Precision Cancer Diagnostic Solutions Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Precision Cancer Diagnostic Solutions Revenue Market Share by Application (2025-2030)

Table 31. North America Precision Cancer Diagnostic Solutions Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Precision Cancer Diagnostic Solutions Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Precision Cancer Diagnostic Solutions Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Precision Cancer Diagnostic Solutions Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Precision Cancer Diagnostic Solutions Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Precision Cancer Diagnostic Solutions Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Precision Cancer Diagnostic Solutions Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Precision Cancer Diagnostic Solutions Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Precision Cancer Diagnostic Solutions Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Precision Cancer Diagnostic Solutions Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Precision Cancer Diagnostic Solutions Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Precision Cancer Diagnostic Solutions Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Precision Cancer Diagnostic Solutions Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Precision Cancer Diagnostic Solutions Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Precision Cancer Diagnostic Solutions Market Size by Country (2025-2030) & (US$ Million)

Table 46. Philips Healthcare Company Detail

Table 47. Philips Healthcare Business Overview

Table 48. Philips Healthcare Precision Cancer Diagnostic Solutions Product

Table 49. Philips Healthcare Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)

Table 50. Philips Healthcare Recent Development

Table 51. Thermo Fisher Scientific Company Detail

Table 52. Thermo Fisher Scientific Business Overview

Table 53. Thermo Fisher Scientific Precision Cancer Diagnostic Solutions Product

Table 54. Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)

Table 55. Thermo Fisher Scientific Recent Development

Table 56. Abbott Laboratories Company Detail

Table 57. Abbott Laboratories Business Overview

Table 58. Abbott Laboratories Precision Cancer Diagnostic Solutions Product

Table 59. Abbott Laboratories Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)

Table 60. Abbott Laboratories Recent Development

Table 61. BD Company Detail

Table 62. BD Business Overview

Table 63. BD Precision Cancer Diagnostic Solutions Product

Table 64. BD Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)

Table 65. BD Recent Development

Table 66. Siemens Healthineers Company Detail

Table 67. Siemens Healthineers Business Overview

Table 68. Siemens Healthineers Precision Cancer Diagnostic Solutions Product

Table 69. Siemens Healthineers Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)

Table 70. Siemens Healthineers Recent Development

Table 71. PHC Holdings Company Detail

Table 72. PHC Holdings Business Overview

Table 73. PHC Holdings Precision Cancer Diagnostic Solutions Product

Table 74. PHC Holdings Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)

Table 75. PHC Holdings Recent Development

Table 76. Agilent Company Detail

Table 77. Agilent Business Overview

Table 78. Agilent Precision Cancer Diagnostic Solutions Product

Table 79. Agilent Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)

Table 80. Agilent Recent Development

Table 81. Sakura Finetek Company Detail

Table 82. Sakura Finetek Business Overview

Table 83. Sakura Finetek Precision Cancer Diagnostic Solutions Product

Table 84. Sakura Finetek Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)

Table 85. Sakura Finetek Recent Development

Table 86. Epredia Company Detail

Table 87. Epredia Business Overview

Table 88. Epredia Precision Cancer Diagnostic Solutions Product

Table 89. Epredia Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)

Table 90. Epredia Recent Development

Table 91. bioMeriux Company Detail

Table 92. bioMeriux Business Overview

Table 93. bioMeriux Precision Cancer Diagnostic Solutions Product

Table 94. bioMeriux Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)

Table 95. bioMeriux Recent Development

Table 96. MDx Health Company Detail

Table 97. MDx Health Business Overview

Table 98. MDx Health Precision Cancer Diagnostic Solutions Product

Table 99. MDx Health Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)

Table 100. MDx Health Recent Development

Table 101. DiaSorin Company Detail

Table 102. DiaSorin Business Overview

Table 103. DiaSorin Precision Cancer Diagnostic Solutions Product

Table 104. DiaSorin Revenue in Precision Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)

Table 105. DiaSorin Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Precision Cancer Diagnostic Solutions Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Precision Cancer Diagnostic Solutions Market Share by Type: 2023 VS 2030

Figure 3. Hardware Features

Figure 4. Software and Services Features

Figure 5. Global Precision Cancer Diagnostic Solutions Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Precision Cancer Diagnostic Solutions Market Share by Application: 2023 VS 2030

Figure 7. Hospital & Diagnostic Centers Case Studies

Figure 8. Laboratories & Research Institutes Case Studies

Figure 9. Precision Cancer Diagnostic Solutions Report Years Considered

Figure 10. Global Precision Cancer Diagnostic Solutions Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Precision Cancer Diagnostic Solutions Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Precision Cancer Diagnostic Solutions Market Share by Region: 2023 VS 2030

Figure 13. Global Precision Cancer Diagnostic Solutions Market Share by Players in 2023

Figure 14. Global Top Precision Cancer Diagnostic Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Solutions as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Precision Cancer Diagnostic Solutions Revenue in 2023

Figure 16. North America Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Precision Cancer Diagnostic Solutions Market Share by Country (2019-2030)

Figure 18. United States Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Precision Cancer Diagnostic Solutions Market Share by Country (2019-2030)

Figure 22. Germany Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Precision Cancer Diagnostic Solutions Market Share by Region (2019-2030)

Figure 30. China Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Precision Cancer Diagnostic Solutions Market Share by Country (2019-2030)

Figure 38. Mexico Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Precision Cancer Diagnostic Solutions Market Share by Country (2019-2030)

Figure 42. Turkey Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia Precision Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Philips Healthcare Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2019-2024)

Figure 45. Thermo Fisher Scientific Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2019-2024)

Figure 46. Abbott Laboratories Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2019-2024)

Figure 47. BD Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2019-2024)

Figure 48. Siemens Healthineers Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2019-2024)

Figure 49. PHC Holdings Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2019-2024)

Figure 50. Agilent Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2019-2024)

Figure 51. Sakura Finetek Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2019-2024)

Figure 52. Epredia Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2019-2024)

Figure 53. bioMeriux Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2019-2024)

Figure 54. MDx Health Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2019-2024)

Figure 55. DiaSorin Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2019-2024)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Oncology Imaging Equipment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1U15802

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global HER2 Tumor Marker Testing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-27D15553

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Targeted Radiotherapy Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2U15903

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Cell-Free Circulating Tumor DNA (ctDNA) Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2W15676

Tue Aug 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions